<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250526065916N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-21</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effects of laser and surgery in accelerating orthodontic treatment</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of piezoincision and photobiomodulation on canine retraction rate in patients undergoing orthodontic treatment</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86710</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method will be simple and using random blocks. Using SATA software, 8 blocks of 3 will be randomly generated. Then, 1 block will be randomly selected from the list and people will be assigned to groups based on the block, Blinding description: This study will be conducted in a double-blind style. The patients and the administrator will be aware of the study groups; however, the person who will follow up the patients as well as the statistical consultant, will not be aware of the study groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Orthodontic Problems.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Photobiomodulation therapy: In the first intervention group, low-level laser therapy was performed twice a week for four weeks via a continuous-wave mode laser (EPIC X, Biolase, USA) with the following characteristics: 940 nm, power 200 mW. A tip cross-section of 4 cm2 with an energy density of 4 J/cm2 (16 J/cm2 for each tooth) was applied to each area for 25 seconds. The laser was applied to 4 peri-tooth areas such as mesilingual, distolingual, distobuccal and mesiobuccal. In addition, the apical, medial and cervical parts of the canine roots in both buccal and lingual areas as well as the angles of the distobuccal and distopalatal lines were irradiated. Intervention 2: Intervention group 2: Piezoincision group: Due to the invasiveness of piezoincision, this procedure will be performed only once. Depending on the degree of keratinized gingiva, 1 or 2 points in the interradicular area of ​​teeth 3 and 5 will be drilled into the bone to a depth of 3 mm using a piezotome device (Acteon, CUBE, France). Intervention 3: Intervention group 3: Piezoincision + photobiomodulation group: In this group, first, based on the degree of keratinized gingiva, 1 or 2 points in the interradicular area of ​​teeth 3 and 5 will be drilled into the bone to a depth of 3 mm using a piezotome device (Acteon, CUBE, France). In addition, low-level laser therapy will be performed twice a week for four weeks via a continuous-wave mode laser (EPIC X, Biolase, USA) with the following characteristics: 940 nm, power 200 mW. A tip cross-section of 4 cm2 with an energy density of 4 J/cm2 (16 J/cm2 for each tooth), applied to each area for 25 seconds. Intervention 4: Control group: No additional intervention will be performed on these patients and orthodontic treatment will be performed using the conventional method.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Avideh Maboudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Deputy for Research and Technology Building, Moalem Square, Sari, Mazandaran province</address>
        <city>sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۸۱۵۷۳۳۹۷۱</zip>
        <telephone>+98 11 3304 4030</telephone>
        <email>avideh.maboudi@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Melika Mollaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Moallem avenue</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 3324 4014</telephone>
        <email>Melika.mollaei.7@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 14 to 27
Healthy patients with good oral hygiene and periodontal status
Class II, div I individuals who require bilateral maxillary first premolar extraction followed by canine retraction
No history of orthodontic treatment</inclusion_criteria>
      <agemin>14 years</agemin>
      <agemax>27 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of systemic diseases
Presence of dental phobia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M26.212</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malocclusion, Angle's class II</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Photobiomodulation therapy: In the first intervention group, low-level laser therapy was performed twice a week for four weeks via a continuous-wave mode laser (EPIC X, Biolase, USA) with the following characteristics: 940 nm, power 200 mW. A tip cross-section of 4 cm2 with an energy density of 4 J/cm2 (16 J/cm2 for each tooth) was applied to each area for 25 seconds. The laser was applied to 4 peri-tooth areas such as mesilingual, distolingual, distobuccal and mesiobuccal. In addition, the apical, medial and cervical parts of the canine roots in both buccal and lingual areas as well as the angles of the distobuccal and distopalatal lines were irradiated.</i_keyword>
      <i_keyword>Intervention group 2: Piezoincision group: Due to the invasiveness of piezoincision, this procedure will be performed only once. Depending on the degree of keratinized gingiva, 1 or 2 points in the interradicular area of ​​teeth 3 and 5 will be drilled into the bone to a depth of 3 mm using a piezotome device (Acteon, CUBE, France).</i_keyword>
      <i_keyword>Intervention group 3: Piezoincision + photobiomodulation group: In this group, first, based on the degree of keratinized gingiva, 1 or 2 points in the interradicular area of ​​teeth 3 and 5 will be drilled into the bone to a depth of 3 mm using a piezotome device (Acteon, CUBE, France). In addition, low-level laser therapy will be performed twice a week for four weeks via a continuous-wave mode laser (EPIC X, Biolase, USA) with the following characteristics: 940 nm, power 200 mW. A tip cross-section of 4 cm2 with an energy density of 4 J/cm2 (16 J/cm2 for each tooth), applied to each area for 25 seconds.</i_keyword>
      <i_keyword>Control group: No additional intervention will be performed on these patients and orthodontic treatment will be performed using the conventional method.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Canine retraction rate. Timepoint: Before intervention, 1 month after intervention, 2 months after intervention. Method of measurement: orthodontic software package.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-23</approval_date>
        <contact_name>Ethics committee of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Deputy of research and technology building, Moalem Square, Mazandaran Province, Sari Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
